## Uncertainty in economic evaluations for immunotherapy from extrapolating models choice and data maturity: a case study of Checkmate-067

Taihang Shao<sup>1*</sup>, Mingye Zhao<sup>1*</sup>, Leyi Liang<sup>1</sup>, Lizheng Shi<sup>2#</sup>, Wenxi Tang<sup>1,3#</sup>

1 Center for Pharmacoeconomics and Outcomes Research, China Pharmaceutical University, Nanjing, China, 211198; 
2 Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, New Orleans, Louisiana, LA 70118; 
3 Department of Public Affairs Management, School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China, 211198

*These authors contributed equally to this work; 
#Corresponding authors

Codes in this repository are used to reproduce this analysis.
Original data and colour figures are also provided in this repository.

Any questions or technical consulting:
Email: cpu_sth@stu.cpu.edu.cn
